abstract |
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders such as schizophrenia and major depressive disorder. Pharmaceutical compositions and methods for making heteroaromatic compounds are provided. Compounds are contemplated to modulate the NMDA receptor. [Selection diagram] None |